Ask your doctor about ImmunoFormulation (IF): A combination of nutraceuticals that can help COVID19 patients


Deprecated: strlen(): Passing null to parameter #1 ($string) of type string is deprecated in /home/medicircle/public_html/script_newsdetails.php on line 75
▴
The immune system is our defensive mechanism of the body that helps in fighting infection. Protecting your immune system with the administration of ImmunoFormulation (IF) can help you keep coronavirus at bay as per the evidence-based study.

COVID19 is caused by the acute respiratory distress syndrome coronavirus has being spread worldwide for more than a year. Although vast knowledge has been gathered about coronavirus, limited options are available for its treatment. We all understand with this coronavirus outbreak that “Prevention is better than cure”. In this context, agents that can act as prophylactics and adjuvants to the therapies are of high value. This includes a good amount of vitamin supplements and nutraceuticals that can help boost your immunity. 

Coronavirus affects and lowers the immune system

Weakened immunity can result in being more prone to infections like COVID19. When it comes to pathological findings, it is now clear that coronavirus involves the affection of the immune system with inflammatory effects. Preventing the coronavirus at an early stage can help you a lot. Taking vitamin supplements and nutraceuticals can help your body prevent the attack of coronavirus. Not to forget, the guidelines of social distancing, sanitizing, and wearing a mask are equally important. 

An observational study with  ImmunoFormulation (IF) treatment in SARS-Co-V-2 positive patients.

A study was carried out to describe the course of the disease SARS-Co-V2 on patients treated with ImmunoFormulation (IF). 

There were two groups of patients analyzed which are as follows:  

1)A group of patients who received ImmunoFormulation (IF) during the course of SARS-CoV-2

2) )A group of patients who did not receive ImmunoFormulation (IF) during the course of SARS-CoV-2

Screening criteria for an observational study 

All the patients attended the private clinic from March to May 2020. The data was collected in September 2020 for analysis. 40 patients were involved in the study who were tested positive in a diagnostic test for SARS-Co-V-2. 20 patients who received treatment with ImmunoFormulation (IF) were compared to another group of 20 patients who received standard care only. 

The screening criteria were as follows: 

Patients were 18 years of age or older  Patients have given written consent to participate in the study  The patients suffering from COVID19 symptoms from March to May 2020  Patients who were tested positive for the SARS-Co-V-2 diagnostic test  Patients with onset of COVID19 >5 days prior to the diagnosis of SARS-Co-V-2 

Results: A total of 40 patients participated in the study ( 20 in  ImmunoFormulation (IF) cohort study  / 20 on control cohort study). The patients were evaluated for efficacy of ImmunoFormulation (IF). The control cohort received standard care only and the  ImmunoFormulation (IF)cohort received standard care + ImmunoFormulation (IF). 

After comparison, It was observed in the  

ImmunoFormulation (IF) cohort observational study showed:

50% mild cases 

30 % moderate cases 

20% severe cases 

In the control cohort, an observational study showed: 

36.2% mild cases

26.3% moderate cases 

36.5% severe cases 

Throughout the observational study, 90% of patients recovered from the ImmunoFormulation (IF) cohort and 47.4% from the control cohort. The percentage of recovery in an observational study is better in the group treated with  ImmunoFormulation (IF). 

The conclusion from Observational study. 

In the treatment of COVID19, it is important to target the SARS-Co-V-2 to eliminate and improve the symptomatology by strengthening the natural defenses. Immune Formulation (IF) helped in abstaining fast recovery and better outcomes. A higher concentration of essential vitamins and minerals inhibited the replication of SARS-Co-V-2 avoiding the virus from entering the cell and multiply. This will help reduce the transmission of viruses from one person to another. 

Importance of  ImmunoFormulation (IF) and nutraceuticals

The study demonstrates that the consumption of vitamin supplements with a good amount of Vitamin D, Vitamin C, Vitamin B, Zinc, Selenium which has good antioxidant and antiinflammatory properties is good for the body to prevent the COVID19 and better recovery. These all vitamins will help contribute to reducing oxidative stress. This study promises the potential role of  ImmunoFormulation (IF) as adjuvant therapy in the COVID19 patients.  

Tags : #medicircle #myhealth #immunesystem #ImmunoFormulation #COVID19

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

Digital Identity Fraud in Healthcare: What India Must KnowNovember 18, 2026
Wearables in Clinical Care: When Should Doctors Trust the Data?November 18, 2026
Cybersecurity for Medical Startups: What Founders MissNovember 18, 2026
Remote Patient Monitoring: The Next Phase of Virtual CareNovember 18, 2026
Digital Health Wallets: Future of Medical Records in IndiaNovember 17, 2026
How Hospitals Can Prepare for a Transparent Healthcare MarketNovember 17, 2026
Childhood Nutrition: Understanding Micronutrient Gaps Beyond CaloriesNovember 16, 2026
Anaemia in Adolescent Girls: Connecting Prevention, Testing and Nutrition SupportNovember 16, 2026
Health Information Exchanges in India: Are Medical Records Finally Going Portable?November 16, 2026
Hospital Accreditation in 2026: What Is Changing Beyond the Checklist?November 16, 2026
Digital Insurance Platforms and India's Health Coverage FutureNovember 14, 2026
ABDM 2.0: India's Digital Health Ecosystem FutureNovember 14, 2026
Vaccine Cold-Chain Management: Protecting Immunisation Quality From Storage to DeliveryNovember 14, 2026
Foodborne Illness Surveillance: How Public Health Systems Track RisksNovember 14, 2026
Interoperability in Indian Healthcare: Why Patient Data Still StrugglesNovember 13, 2026
Tuberculosis Contact Screening: How Preventive Care Works Around ExposureNovember 13, 2026
COPD Care in India: Linking Diagnosis, Inhaler Education and Follow-UpNovember 13, 2026
Management of ANCA Glomerulonephritis: Induction & Maintenance ProtocolsNovember 12, 2026
Smart Hospital Command Centres Transforming IndiaNovember 12, 2026
Gamma Knife Surgery in India: What You Need to KnowNovember 12, 2026